In hypertensive patients characterized by high serum ICAM-1 concentration, endocan released by activated endothelium could compete with ICAM-1 for the integrin LFA-1, which is the alpha L/beta2 leukocyte ligand for ICAM-1. The gene discussed is ICAM1; the disease is hypertensive disorder.